Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check3 days agoChange DetectedUpdated the displayed software version label for the study details page from “Revision: v3.5.2” to “Revision: v3.5.3.”SummaryDifference0.1%

- Check10 days agoChange DetectedRevision: v3.5.2 replaces the previous Revision: v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check53 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check75 days agoChange DetectedAn update to the site revision indicator from v3.4.1 to v3.4.2 was applied; no changes to study content, eligibility criteria, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.